Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Ballinger

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Anticancer Research|May 16, 2000
Sestamibi accumulation in human nasopharyngeal carcinoma cell lines in vitroJ R Ballinger, J H Li
Clinical Nuclear Medicine|June 11, 1999
Sentinel node detection and definition may depend on the imaging agent and timingI Boxen, D McCready, J R Ballinger
Nuclear Medicine Communications|March 24, 1999
99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancerT Muzzammil, J R Ballinger, M J Moore
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1981
Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparationM Der, J R Ballinger, B M Bowen
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Routine determination of radiochemical purity of 99mTc-MIBIA Proulx, J R Ballinger, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1987
Technetium-99m diethyldithiocarbamate (DDC): comparison with thallium-201 DDC as an agent for brain imagingJ R Ballinger, B Gerson, K Y Gulenchyn
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumorsT Muzzammil, M J Moore, J R Ballinger
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Technetium-99m dithiocarbamates as potential brain agents: evaluation of aliphatic and amine-containing analoguesJ R Ballinger, B Gerson, K Y Gulenchyn
Nuclear Medicine Communications|April 30, 2003
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour modelsJ R Ballinger, V Hsue, A M Rauth
Biochemical Pharmacology|August 6, 2000
Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxiaT Melo, J R Ballinger, A M Rauth
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Anticancer Research|May 16, 2000
Sestamibi accumulation in human nasopharyngeal carcinoma cell lines in vitroJ R Ballinger, J H Li
Clinical Nuclear Medicine|June 11, 1999
Sentinel node detection and definition may depend on the imaging agent and timingI Boxen, D McCready, J R Ballinger
Nuclear Medicine Communications|March 24, 1999
99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancerT Muzzammil, J R Ballinger, M J Moore
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1981
Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparationM Der, J R Ballinger, B M Bowen
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Routine determination of radiochemical purity of 99mTc-MIBIA Proulx, J R Ballinger, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1987
Technetium-99m diethyldithiocarbamate (DDC): comparison with thallium-201 DDC as an agent for brain imagingJ R Ballinger, B Gerson, K Y Gulenchyn
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumorsT Muzzammil, M J Moore, J R Ballinger
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Technetium-99m dithiocarbamates as potential brain agents: evaluation of aliphatic and amine-containing analoguesJ R Ballinger, B Gerson, K Y Gulenchyn
Nuclear Medicine Communications|April 30, 2003
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour modelsJ R Ballinger, V Hsue, A M Rauth
Biochemical Pharmacology|August 6, 2000
Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxiaT Melo, J R Ballinger, A M Rauth
Pageof 9